Inside the research
Waters Corporation
WAT Research profile · latest available data
Price overview
$433.54
▲ +3.24 (+0.8%)
| 52w hi | $433.54 |
|---|---|
| 52w lo | $283.32 |
| Vol | 662.50K |
| As of | 25 Sep 2026 |
The Verdict
Our score +0.35
| Short | +0.25 |
|---|---|
| Medium | +0.46 |
| Long | +0.33 |
computed 2026-09-27
Key fundamentals
Waters Corporation
Healthcare · Diagnostics & Research
| Market cap | $42.57B |
|---|---|
| Enterprise value | $47.53B |
| Trailing P/E | 109.76x |
| Forward P/E | 26.20x |
| EV / EBITDA | 32.73x |
| P / S (ttm) | 9.17x |
| Profit margin | 3.6% |
| Return on equity | 1.9% |
| Revenue growth | +113.4% |
| Debt / equity | 36.05 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.24 | |
| Sector | +0.08 | |
| Technical | +0.20 | |
| Earnings | +0.00 | |
| Sentiment | +0.02 |
macro × 1.00 · 2026-09-27
Business overview
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
Risk Metrics
| Beta vs SPX | 0.98 |
|---|---|
| Corr SPX | 0.41 |
| Annual vol | 38.2% |
| Annual ret | +19.9% |
| Sharpe | 0.52 |
| Max DD | -33.4% |
Window: 504 trading days (504 obs)
Analyst Coverage
| Mean PT | $397.32 |
|---|---|
| High / Low | $480.00 / $345.00 |
| Median | $386.00 |
| Analysts | 22 |
| Strong Buy | 2 | |
|---|---|---|
| Buy | 11 | |
| Hold | 9 | |
| Sell | 0 | |
| Strong Sell | 0 |
Recent rating actions
| 2026-05-07 | Barclays | → Overweight |
| 2026-05-06 | UBS | → Neutral |
| 2026-05-06 | TD Cowen | → Hold |
| 2026-05-06 | JP Morgan | → Neutral |
| 2026-04-13 | UBS | → Neutral |
| 2026-03-25 | Deutsche Bank | → Hold |
Officers & Board
| Founder | Jim Waters current |
|---|
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-04 | Earnings Release, Exhibits | read |
| 2026-05-22 | Shareholder Vote | read |
| 2026-05-05 | Earnings Release, Exhibits | read |
| 2026-03-23 | Material Agreement, Material Obligation… | read |
| 2026-03-16 | Other Material Event, Exhibits | read |
| 2026-02-09 | Material Agreement, Acquisition / Disposition… | read |
| 2026-02-09 | Earnings Release, Exhibits | read |
| 2026-01-27 | Shareholder Vote, Reg FD Disclosure… | read |
| 2026-01-16 | Other Material Event | read |
| 2026-01-12 | Reg FD Disclosure, Exhibits | read |
| 2025-11-04 | Earnings Release, Exhibits | read |
| 2025-08-04 | Earnings Release, Exhibits | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-06 | KUEBLER CHRISTOPHER A | Option exercise | 3.63K | $494.70K | |
| 2026-08-06 | KUEBLER CHRISTOPHER A | Sell | 3.63K | $1.44M | |
| 2026-06-30 | Knight Heather | Grant | 63 | — | |
| 2026-06-30 | Jiang Wei | Grant | 67 | — | |
| 2026-06-24 | Carpio Robert L III | SVP Waters Analytical Sci | Withheld for tax | 189 | $69.78K |
| 2026-05-12 | Chaubal Amol | SVP & Chief Financial Off | Withheld for tax | 239 | $84.18K |
| 2026-04-06 | Bennett Jianqing | SVP Waters Adv. Diagnosti | Withheld for tax | 302 | $91.84K |
| 2026-03-31 | Jiang Wei | Grant | 64 | — | |
| 2026-03-31 | Knight Heather | Grant | 68 | — | |
| 2026-03-16 | Jiang Wei | Buy | 500 | $144.73K |
Flow & Concentration
| Insider 180d net | -$1.44M |
|---|---|
| Insider buys / sells | 0 / 1 |
| Insider bias | Neutral |
| 13F holders | 8 |
| Top-5 share | 97.3% |
| HHI | 3,237 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| State Street Corp | $1.64B | 4.38M |
| Norges Bank (Norway sovereign) | $500.72M | 1.34M |
| Fidelity / FMR LLC | $346.82M | 924.74K |
| Millennium Management | $335.53M | 894.66K |
| Capital Research / Capital World | $260.63M | 694.95K |
| Citadel Advisors | $64.21M | 171.21K |
| AQR Capital Management | $19.42M | 52.65K |
| T. Rowe Price Group | $816.82K | 2.18M |
As of 2026-06-30
Federal Contracts
| Amount | Agency | Description |
|---|---|---|
| $6.68M | Department of Defense | IGF::OT::IGF IA INFORMATION ASSURANCE |
| $4.69M | Department of Commerce | LOWER ESTUARY - TECHNICAL/NON-TECHNICAL SCIENTIFIC SERVICES |
| $2.58M | Department of Defense | PREVENTATIVE MAINTENANCE FOR THE WALTER REED ARMY INSTITUTE OF RESEARCH SUPPORTI |
| $2.16M | Department of Health and Human Services | WATERS LAB EQUIPMENT MAINTENANCE AGREEMENT |
| $2.08M | Department of Health and Human Services | CHROMATOGRAPHY DATA SYSTEM FOR OMPSLO SLEP (VARIOUS SITES) |
| $2.06M | General Services Administration | SPECIAL FORCES NSW PACKS |
| $1.67M | Environmental Protection Agency | LIQUID CHROMATOGRAPH-TRIPLE QUADRUPOLE MASS SPECTROMETER (LC-MS/MS TRIPLE) SYSTE |
| $1.65M | Department of Defense | ANALYTICAL INFORMATION TECHNOLOGY (IT) SUPPORT SERVICES |
SEC Filings
The Long Run
FY 2009–2025 · 17 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $636.84M | -5.2% | |
| Gross profit | $242.79M | -19.7% | |
| Operating income | $817.68M | +5.5% | |
| Net income | $642.23M | -9.3% | |
| Cash from ops | $652.55M | +3.8% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $428.71 | $435.93 | $425.67 | $433.54 | 662.50K |
| Sep 24 | $418.33 | $436.34 | $418.00 | $430.30 | 1.03M |
| Sep 23 | $428.17 | $430.00 | $420.00 | $420.57 | 743.60K |
| Sep 22 | $424.13 | $433.09 | $422.83 | $425.74 | 648.30K |
| Sep 21 | $425.80 | $427.76 | $420.75 | $423.92 | 782.40K |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →